Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7523362 | 0.87 | SHBG (0.44) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL7529731 | 0.87 | SHBG (0.44) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL212514 | 0.87 | SHBG (0.47) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL22271434 | 0.82 | SHBG (0.43) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL8351608 | 0.81 | SHBG (0.40) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL8347012 | 0.81 | SHBG (0.40) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL7522113 | 0.81 | SHBG (0.48) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL8345472 | 0.81 | SHBG (0.42) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL7094938 | 0.79 | AMY1A (0.47) | SHBGALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL22039928 | 0.78 | SHBG (0.40) | SHBGALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43067-E1 | Method for producing new polynuclear poly(formylphenol) | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-7750190-B2 | reacting hexamethylene tetramine in presence of acid; industrial scale; photoresists | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20090182175-A1 | METHOD FOR PRODUCING NEW POLYNUCLEAR POLY(FORMYLPHENOL) | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182175-A1 | METHOD FOR PRODUCING NEW POLYNUCLEAR POLY(FORMYLPHENOL) | PCBP1, FPR2, PNKP | SHBG 3146/4885ALDH1A1 3100/4885KDM4E 4086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.